News
LONDON, UK I June 02, 2025 I GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has accepted for review the NDA for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback